# Experience of a Romanian Lyme Borreliosis Centre in the Multidisciplinary Management of Patients Evaluated for Suspected Lyme Neuroborreliosis

**Authors:** Violeta Briciu, Angela Monica Ionicǎ, Simona Mureşan, Astrid Binder, Cristina Cismaru, Oana Stan, Blanca Szolga, Cǎtǎlina Hǎpǎianu, Mirela Flonta, Mihaela Lupşe

PMC · DOI: 10.3390/microorganisms14020264 · Microorganisms · 2026-01-23

## TL;DR

This study from a Romanian Lyme Borreliosis Centre highlights the challenges in diagnosing Lyme neuroborreliosis and shows that it is likely underdiagnosed in the country.

## Contribution

The study provides insights into the epidemiology and differential diagnosis of Lyme neuroborreliosis in a highly endemic area in Romania.

## Key findings

- Only 1.65% of suspected cases met the criteria for definite Lyme neuroborreliosis.
- LNB was excluded in 70.95% of patients, with more demyelinating diseases in this group.
- The study suggests that LNB is underdiagnosed and underreported in Romania.

## Abstract

Lyme neuroborreliosis (LNB) may mimic other neurological diseases, while neurological diseases may be misdiagnosed as LNB. The aims of the study were to contribute to the knowledge regarding the epidemiology and clinical manifestations of LNB, discuss differential diagnosis, and compare characteristics in patients with and without LNB. We present patients evaluated for suspected LNB by the multidisciplinary team of a “Lyme Borreliosis Centre” in a highly endemic area in Romania. A retrospective study was performed between January 2011 and October 2023 on patients referred for suspected LNB based on neurological manifestations and positive serology for Borrelia burgdorferi antibodies using two-tier testing. A lumbar puncture was performed for diagnosis, and the European LNB definition was used for classification. Of three hundred and three LNB suspected patients, five (1.65%) were classified as definite LNB, eighty-three (27.39%) as possible LNB, and in two hundred and fifteen patients (70.95%), LNB was excluded. Comparing the definite/possible to excluded LNB patients, there was no significant difference in neurological symptoms/manifestations. The patients presented fifty-one neurological, twelve rheumatological, and seven psychiatric diagnoses, with significantly more meningitis/encephalitis/myelitis diagnoses in the definite/possible LNB group, and more demyelinating disease and discopathy in the LNB-excluded group. Considering the complex differential diagnoses, access to laboratory diagnostics and multidisciplinary management should be available in centres that evaluate suspected LNB patients. Comparing results with data from the national surveillance system, we conclude that LNB is underdiagnosed/underreported in Romania.

## Linked entities

- **Diseases:** meningitis (MONDO:0021108), encephalitis (MONDO:0019956), myelitis (MONDO:0002565), demyelinating disease (MONDO:0002562)

## Full-text entities

- **Diseases:** Acute stroke (MESH:D020521), vertigo (MESH:D014717), fatigue (MESH:D005221), neurological disease (MESH:D020271), autoimmune (MESH:D001327), lesion (MESH:D009059), white matter lesions (MESH:D056784), gait disorder (MESH:D020233), myelitis (MESH:D009187), cerebral oedema (MESH:D001929), dermatomyositis (MESH:D003882), vomiting (MESH:D014839), tick (MESH:D013985), cranial nerve deficits (MESH:D003389), post-traumatic encephalopathy (MESH:D000070627), anxiety disorder (MESH:D001008), inability (MESH:C564980), acute meningoencephalitis (MESH:D000208), leukoaraiosis (MESH:D049292), fever (MESH:D005334), chronic fatigue syndrome (MESH:D015673), arthrosis (MESH:D010003), cerebral microangiopathy (MESH:D059345), neurologic deficits (MESH:D009461), LNB (MESH:D020852), Clippers syndrome (MESH:D013577), Parkinson's disease (MESH:D010300), chronic lymphocytic inflammation (MESH:D015451), sleep disorder/ (MESH:D012893), thoracic pain (MESH:D010146), syphilis (MESH:D013587), somatization disorder (MESH:D013001), cerebral vasculitis (MESH:D020293), glioma (MESH:D005910), headache (MESH:D006261), inflammation (MESH:D007249), myasthenia (MESH:D020294), injury to (MESH:D014947), tick bite (MESH:D064927), anxiety (MESH:D001007), -cerebral atrophy (MESH:D001284), lymphocytic meningitis (MESH:D008580), B. burgdorferi infection (MESH:D008193), radiculopathy (MESH:D011843), spondylosis (MESH:D055009), malignancy (MESH:D009369), polyneuropathy (MESH:D011115), cognitive or psychiatric disorders (MESH:D001523), Parkinson-like symptoms (MESH:D010302), dementia (MESH:D003704), Parsonage Turner syndrome (MESH:D020968), Acrodermatitis chronica atrophicans (MESH:D000169), adjustment disorder (MESH:D000275), depression (MESH:D003866), neuropathic pain (MESH:D009437), PTLDS (MESH:D000077342), memory and speech disorders (MESH:D013064), neurosarcoidosis (MESH:C535814), Infectious Diseases (MESH:D003141), memory disorders (MESH:D008569)
- **Chemicals:** steroids (MESH:D013256), ceftriaxone (MESH:D002443)
- **Species:** Borreliella garinii (Borrelia genomic group 20047, species) [taxon 29519], Borreliella afzelii (Borrellia group VS461, species) [taxon 29518], Borreliella burgdorferi (Lyme disease spirochete, species) [taxon 139], [Borrelia] lusitaniae (species) [taxon 100177], Homo sapiens (human, species) [taxon 9606], Borreliella valaisiana (species) [taxon 62088], Mycobacterium tuberculosis (species) [taxon 1773]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943279/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12943279/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943279/full.md

---
Source: https://tomesphere.com/paper/PMC12943279